Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome
Sung Eun Wang, Yan Xiong, Mi‐Ae Jang, Kwang‐Su Park, Meaghan Donahue, Julia Velez, Jian Jin, Yong‐hui Jiang
Topics & Concepts
EpigeneticsBiologyCandidate geneGenePharmacologyBioinformaticsGeneticsGenetic Syndromes and ImprintingEpigenetics and DNA MethylationGenetics and Neurodevelopmental Disorders